Umoja Biopharma
Likely to Engage tag.Highly Engaged Employees

Blood & Organ Banks · Washington, United States · 51-200 Employees

View Company Info for Free

Overview

Headquarters

1150 Eastlake Ave E Ste 400, Seattle, Wa...

Revenue

$40.2 Million

Industry

Blood & Organ Banks Manufacturing Pharmaceuticals Business Services Healthcare Services Research & Development

About Umoja Biopharma

Umoja Biopharma is pioneering immunotherapy by developing in vivo CAR T cell therapies aimed at improving cancer treatment accessibility. Their flagship VivoVec platform generates CAR T cells directly within a patient's body, eliminating the lengthy manufacturing process associated with traditional therapies. The company employs a fully in-house lentiviral manufacturing model to ensure reliable supply and quality control. Their pipeline focuses on cancer treatments, with potential applications in other medical conditions.Explore more
Umoja Biopharma's Social MediaSIC Code 28,283NAICS Code 32,325Show more

Umoja Biopharma Org Chart

PhoneEmail
Ryan Crisman, Co-Founder & Chief Technology Officer at Umoja Biopharma
United States flag for contact location.

Co-Founder & Chief Technology Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
TK
United States flag for contact location.

Vice President, Analytical Development

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Compare Similar Companies to Umoja Biopharma

Compare insights from companies similar to Umoja Biopharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Umoja Biopharma

$40.2M
51-200
Private
$363M
2019
Ryan Crisman, Co-Founder & Chief Technology Officer at Umoja Biopharma
Ryan CrismanCo-Founder & Chief Technology Officer
$18.8M
51-200
Private
$243.5M
2015
SH
Stephen HarbinChief Operating Officer & Chief of Staff
$14.9M
51-200
Private
-
1996
JC
Jeremy CromerManager, Regulatory Affairs
$11.9M
51-200
Private
-
2014
N/A
$8.4M
51-200
Private
-
2015
JU
Jeffrey UcranChief Operating Officer
$5.4M
51-200
Private
-
2008
EG
Elizabeth GarciaVivarium Technician
Illustration of an envelope

Umoja Biopharma Tech Stack

A closer look at the technologies used by Umoja Biopharma

Top Blood & Organ Banks Companies

Frequently Asked Questions Regarding Umoja Biopharma

What is Umoja Biopharma's official website?
Umoja Biopharma's official website is www.umoja-biopharma.com
What is Umoja Biopharma's Revenue?
Umoja Biopharma's revenue is $40.2 Million
What is Umoja Biopharma's SIC code?
Umoja Biopharma's SIC: 28,283
What is Umoja Biopharma's NAICS code?
Umoja Biopharma's NAICS: 32,325
How many employees does Umoja Biopharma have?
Umoja Biopharma has 51-200 employees
What industry does Umoja Biopharma belong to?
Umoja Biopharma is in the industry of: Blood & Organ Banks, Manufacturing, Pharmaceuticals
What is Umoja Biopharma competition?
Umoja Biopharma top competitors include: Dragonfly Therapeutics, Vaccine & Gene Therapy Institute of Florida, Genitope, StemImmune
What technology does Umoja Biopharma use?
Some of the popular technologies that Umoja Biopharma uses are: DocuSign, WooCommerce, WordPress.org, PHP
Who is the CTO of Umoja Biopharma?
Umoja Biopharma's CTO is Ryan Crisman
What does Umoja Biopharma do?

Umoja Biopharma is pioneering immunotherapy by developing in vivo CAR T cell therapies aimed at improving cancer treatment accessibility. Their flagship VivoVec platform generates CAR T cells directly within a patient's body, eliminating the lengthy manufacturing process associated with traditional therapies. The company employs a fully in-house le... ntiviral manufacturing model to ensure reliable supply and quality control. Their pipeline focuses on cancer treatments, with potential applications in other medical conditions.Read More

What are Umoja Biopharma social media links?
Umoja Biopharma Linkedin page Umoja Biopharma Twitter page
Who invested in Umoja Biopharma?
Umoja Biopharma has 27 investors including Presight Capital, MPM BioImpact, Qiming Venture Partners USA and MPM Capital.
Is Umoja Biopharma a public company?
Umoja Biopharma is private company therefore does not currently have an official ticker symbol
See more information about Umoja Biopharma

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.